Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company specialising in the neurology market.
Britannia focuses on innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease.
If you are interested in viewing any of our current vacancies please go to: https://www.britannia-pharm.co.uk/about/join-our-team
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the GooglePlay or Apple App Store. Adverse events should also be reported to Britannia Pharmaceuticals Ltd. at dso@britannia-pharm.com or 0808 196 8585.
Pharmaceutical Manufacturing, Chemotherapeutic preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics, Pharmaceutical veterinary preparations, Pharmaceutical preparations, generic, Herbal preparations, medicinal herbs and infusions, Immunological preparations, Pharmaceutical preparations for metabolism, nutrition, alimentary systems
HQ Location
200 Longwater Avenue
Green Park
Reading, Berkshire RG2 6GP, GB